{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:45:48Z","timestamp":1792791948397,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography A"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.chroma.2023.464535","type":"journal-article","created":{"date-parts":[[2023,11,26]],"date-time":"2023-11-26T09:57:58Z","timestamp":1700992678000},"page":"464535","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Hydrophilic interaction liquid chromatography with mass spectrometry for the separation and identification of antisense oligonucleotides impurities and nusinersen metabolites"],"prefix":"10.1016","volume":"1713","author":[{"given":"Zuzana","family":"Vos\u00e1hlov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4988-8322","authenticated-orcid":false,"given":"Kv\u011bta","family":"Kal\u00edkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1199-1287","authenticated-orcid":false,"given":"Martin","family":"Gilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub","family":"Szymarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Mazurkiewicz-Be\u0142dzi\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylwia","family":"Studzi\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chroma.2023.464535_bib0001","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/jimd.12251","article-title":"Opportunities and challenges for antisense oligonucleotide therapies","volume":"44","author":"Kuijper","year":"2021","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.chroma.2023.464535_bib0002","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3390\/cells9010137","article-title":"RNA-based therapeutics: from antisense oligonucleotides to miRNAs","volume":"9","author":"Bajan","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.chroma.2023.464535_bib0003","first-page":"194","article-title":"Nusinersen: a novel antisense oligonucleotide for the treatment of spinal muscular atrophy","volume":"24","author":"Neil","year":"2019","journal-title":"J. Pediatr. Pharmacol. Ther."},{"key":"10.1016\/j.chroma.2023.464535_bib0004","first-page":"38","article-title":"Rise and fall of fomivirsen, the first approved gene silencing medicine\u2014A historical review","volume":"92","author":"Bege","year":"2022","journal-title":"Acta Pharm Hung"},{"key":"10.1016\/j.chroma.2023.464535_bib0005","doi-asserted-by":"crossref","first-page":"14533","DOI":"10.1074\/jbc.271.24.14533","article-title":"Nuclease resistance and antisense activity of modified oligonucleotides targeted to Ha-ras","volume":"271","author":"Monia","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.chroma.2023.464535_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113105","article-title":"Characterization of therapeutic oligonucleotides by liquid chromatography","volume":"182","author":"Goyon","year":"2020","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.chroma.2023.464535_bib0007","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41573-020-0075-7","article-title":"Advances in oligonucleotide drug delivery","volume":"19","author":"Roberts","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.chroma.2023.464535_bib0008","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0968-0896(99)00275-8","article-title":"Stereo-enriched phosphorothioate oligodeoxynucleotides: synthesis, biophysical and biological properties","volume":"8","author":"Yu","year":"2000","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.chroma.2023.464535_bib0009","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1089\/nat.2017.0691","article-title":"Impurities in oligonucleotide drug substances and drug products","volume":"27","author":"Capaldi","year":"2017","journal-title":"Nucl. Acid Ther."},{"key":"10.1016\/j.chroma.2023.464535_bib0010","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.omtn.2019.07.006","article-title":"Metabolite profiling of the antisense oligonucleotide eluforsen using liquid chromatography-mass spectrometry","volume":"17","author":"Kim","year":"2019","journal-title":"Mol. Ther. - Nucl. Acids"},{"key":"10.1016\/j.chroma.2023.464535_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2022.463201","article-title":"Phosphorothioate oligonucleotides separation in ion-pairing reversed-phase liquid chromatography: effect of ion-pairing system","volume":"1676","author":"Kadlecov\u00e1","year":"2022","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2023.464535_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2022.463349","article-title":"Analytical techniques for characterizing diastereomers of phosphorothioated oligonucleotides","volume":"1678","author":"Chen","year":"2022","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2023.464535_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2021.462184","article-title":"Analytical characterization of DNA and RNA oligonucleotides by hydrophilic interaction liquid chromatography-tandem mass spectrometry","volume":"1648","author":"Huang","year":"2021","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2023.464535_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2023.464475","article-title":"Ion-pair reversed-phase and hydrophilic interaction chromatography methods for analysis of phosphorothioate oligonucleotides","volume":"1712","author":"Gilar","year":"2023","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2023.464535_bib0015","doi-asserted-by":"crossref","first-page":"e4088","DOI":"10.1002\/bmc.4088","article-title":"Chromatographic approaches for the characterization and quality control of therapeutic oligonucleotide impurities","volume":"32","author":"El Zahar","year":"2018","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.chroma.2023.464535_bib0016","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1021\/jasms.0c00179","article-title":"Current state of oligonucleotide characterization using liquid chromatography\u2013mass spectrometry: insight into critical issues","volume":"31","author":"Sutton","year":"2020","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.chroma.2023.464535_bib0017","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0021-9673(00)96972-3","article-title":"Hydrophilic-interaction chromatography for the separation of peptides, nucleic acids and other polar compounds","volume":"499","author":"Alpert","year":"1990","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2023.464535_bib0018","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1039\/c0an00399a","article-title":"Separation and identification of oligonucleotides by hydrophilic interaction liquid chromatography (HILIC)\u2014Inductively coupled plasma mass spectrometry (ICPMS)","volume":"135","author":"Easter","year":"2010","journal-title":"Analyst"},{"key":"10.1016\/j.chroma.2023.464535_bib0019","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1039\/c3ay26519f","article-title":"Separation and identification of phosphorothioate oligonucleotides by HILIC-ESIMS","volume":"5","author":"Easter","year":"2013","journal-title":"Anal. Methods"},{"key":"10.1016\/j.chroma.2023.464535_bib0020","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jchromb.2016.11.001","article-title":"Application of hydrophilic interaction liquid chromatography coupled with mass spectrometry in the analysis of phosphorothioate oligonucleotides in serum","volume":"1040","author":"Studzi\u0144ska","year":"2017","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.chroma.2023.464535_bib0021","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.chroma.2019.02.016","article-title":"Oligonucleotide analysis by hydrophilic interaction liquid chromatography-mass spectrometry in the absence of ion-pair reagents","volume":"1595","author":"Lobue","year":"2019","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2023.464535_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2019.460716","article-title":"Evaluation of hydrophilic interaction liquid chromatography, capillary zone electrophoresis and drift tube ion-mobility quadrupole time of flight mass spectrometry for the characterization of phosphodiester and phosphorothioate oligonucleotides","volume":"1614","author":"Demelenne","year":"2020","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2023.464535_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2020.461100","article-title":"Application of hydrophilic interaction liquid chromatography coupled with tandem mass spectrometry for the retention and sensitivity studies of antisense oligonucleotides","volume":"1622","author":"Kilanowska","year":"2020","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2023.464535_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2023.463785","article-title":"Comprehensive evaluation of zwitterionic hydrophilic liquid chromatography stationary phases for oligonucleotide characterization","volume":"1690","author":"Lardeux","year":"2023","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2023.464535_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2023.464327","article-title":"Characterization of antisense oligonucleotide and guide ribonucleic acid diastereomers by hydrophilic interaction liquid chromatography coupled to mass spectrometry","volume":"1708","author":"Goyon","year":"2023","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2023.464535_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.114439","article-title":"Impact of nonspecific adsorption to metal surfaces in ion pair-RP LC-MS impurity analysis of oligonucleotides","volume":"208","author":"Guimaraes","year":"2022","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.chroma.2023.464535_bib0027","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.4155\/bio-2021-0115","article-title":"Assessing the impact of nonspecific binding on oligonucleotide bioanalysis","volume":"13","author":"Nguyen","year":"2021","journal-title":"Bioanalysis"},{"key":"10.1016\/j.chroma.2023.464535_bib0028","doi-asserted-by":"crossref","first-page":"5092","DOI":"10.1021\/ac000225s","article-title":"Analysis of the degradation of oligonucleotide strands during the freezing\/thawing processes using MALDI-MS","volume":"72","author":"Davis","year":"2000","journal-title":"Anal. Chem."},{"key":"10.1016\/j.chroma.2023.464535_bib0029","doi-asserted-by":"crossref","first-page":"10166","DOI":"10.3390\/ijms231710166","article-title":"Development of the method for nusinersen and its metabolites identification in the serum samples of children treated with spinraza for spinal muscular atrophy","volume":"23","author":"Studzi\u0144ska","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.chroma.2023.464535_bib0030","doi-asserted-by":"crossref","first-page":"7453","DOI":"10.1007\/s00216-020-02878-0","article-title":"Studying in vitro metabolism of the first and second generation of antisense oligonucleotides with the use of ultra-high-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry","volume":"412","author":"Kilanowska","year":"2020","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.chroma.2023.464535_bib0031","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1093\/nar\/gkv145","article-title":"RoboOligo: software for mass spectrometry data to support manual and de novo sequencing of post-transcriptionally modified ribonucleic acids","volume":"43","author":"Sample","year":"2015","journal-title":"Nucl. Acids Res."},{"key":"10.1016\/j.chroma.2023.464535_bib0032","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S1044-0305(01)00354-3","article-title":"SOS: a simple interactive program for ab initio oligonucleotide sequencing by mass spectrometry","volume":"13","author":"Rozenski","year":"2002","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.chroma.2023.464535_bib0033","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/1044-0305(92)85019-G","article-title":"Tandem mass spectrometry of small, multiply charged oligonucleotides","volume":"3","author":"Mcluckey","year":"1992","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.chroma.2023.464535_bib0034","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1002\/jssc.202200165","article-title":"Contribution of ionic interactions to stationary phase selectivity in hydrophilic interaction chromatography","volume":"45","author":"Gilar","year":"2022","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.chroma.2023.464535_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2022.463473","article-title":"Phosphorothioate oligonucleotides separation in ion-pairing reversed-phase liquid chromatography: effect of temperature","volume":"1681","author":"Kadlecov\u00e1","year":"2022","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2023.464535_bib0036","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1002\/jssc.200700624","article-title":"Impact of column temperature and mobile phase components on selectivity of hydrophilic interaction chromatography (HILIC)","volume":"31","author":"Hao","year":"2008","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.chroma.2023.464535_bib0037","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1089\/nat.2021.0056","article-title":"Assay, purity, and impurity profile of phosphorothioate oligonucleotide therapeutics by ion pair\u2013HPLC\u2013MS","volume":"32","author":"Rentel","year":"2022","journal-title":"Nucl. Acid Ther."},{"key":"10.1016\/j.chroma.2023.464535_bib0038","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1089\/nat.2022.0054","article-title":"Drug metabolism and pharmacokinetics of antisense oligonucleotide therapeutics: typical profiles, evaluation approaches, and points to consider compared with small molecule drugs","volume":"33","author":"Takakusa","year":"2023","journal-title":"Nucl. Acid Ther."},{"key":"10.1016\/j.chroma.2023.464535_bib0039","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.drudis.2018.05.030","article-title":"Drug metabolism and pharmacokinetic strategies for oligonucleotide- and mRNA-based drug development","volume":"23","author":"Andersson","year":"2018","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.chroma.2023.464535_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2023.125173","article-title":"Improvement of serum sample preparation and chromatographic analysis of nusinersen used for the treatment of spinal muscular atrophy","volume":"267","author":"Studzi\u0144ska","year":"2024","journal-title":"Talanta"}],"container-title":["Journal of Chromatography A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021967323007604?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021967323007604?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T18:02:28Z","timestamp":1762192948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021967323007604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":40,"alternative-id":["S0021967323007604"],"URL":"https:\/\/doi.org\/10.1016\/j.chroma.2023.464535","relation":{},"ISSN":["0021-9673"],"issn-type":[{"value":"0021-9673","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hydrophilic interaction liquid chromatography with mass spectrometry for the separation and identification of antisense oligonucleotides impurities and nusinersen metabolites","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography A","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chroma.2023.464535","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"464535"}}